Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Andros Pharmaceuticals Co., Ltd. (6917) Income Statement

Andros Pharmaceuticals Co., Ltd. Income Statement

Last quarter (Q2 2026), Andros Pharmaceuticals Co., Ltd.'s total revenue was NT$5.84M. In Q2, Andros Pharmaceuticals Co., Ltd.'s net income was NT$-25.82M. See Andros Pharmaceuticals Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 5.55MNT$ 203.00KNT$ 805.00KNT$ 1.71MNT$ 13.31M
NT$ -4.96MNT$ 10.00KNT$ 313.00KNT$ 966.00KNT$ 8.59M
NT$ 70.67MNT$ 89.62MNT$ 74.02MNT$ 47.73MNT$ 43.50M
Depreciation and AmortizationNT$ 6.76MNT$ 6.12MNT$ 6.20MNT$ 6.36MNT$ 6.87M
NT$ -68.87MNT$ -71.65MNT$ -61.50MNT$ -34.35MNT$ -29.74M
NT$ -75.64MNT$ -89.61MNT$ -73.71MNT$ -40.71MNT$ -36.61M
NT$ 22.11MNT$ 11.51MNT$ 5.57MNT$ -464.00KNT$ -500.00K
NT$ -53.52MNT$ -78.10MNT$ -68.14MNT$ -41.17MNT$ -37.11M
NT$ -53.78MNT$ -78.28MNT$ -68.16MNT$ -41.18MNT$ -37.13M
Per Share Metrics
Basic EPSNT$ -1.16NT$ -2.15NT$ -1.87NT$ -1.25NT$ -1.37
Diluted EPSNT$ -1.16NT$ -1.70NT$ -1.87NT$ -1.25NT$ -1.37
Weighted Average Shares Outstanding46.31M36.45M36.45M33.02M27.15M
Weighted Average Shares Outstanding (Diluted)46.31M46.16M36.45M33.02M27.15M

Currency in TWD

Andros Pharmaceuticals Co., Ltd. Earnings and Revenue History

-100M-50M050M-45000 %-30000 %-15000 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin